NewEdge Advisors’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
NewEdge Advisors's ACLS Position: Q2 2026 in Review
NewEdge Advisors increased its Axcelis (ACLS) stake by 248% in Q2 2026, buying an estimated $61.4K and bringing the position to 581 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #2924.
NewEdge Advisors first reported a position in ACLS in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.58M in Q2 2023. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- NewEdge Advisors held 581 shares of Axcelis worth $110K as of Q2 2026.
- NewEdge Advisors bought 414 Axcelis shares in Q2 2026, an estimated $61.4K.
- Axcelis made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2924 holding.
- NewEdge Advisors first reported a position in Axcelis in Q4 2021 and has held it in 16 quarters since.
- NewEdge Advisors's Axcelis position peaked at $1.58M in Q2 2023.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.